Loading...

Prakash Deedwania, MD

Title(s)Professor, Dean's Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Deedwania P. The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease. J Am Heart Assoc. 2018 Oct 16; 7(20):e010752. PMID: 30371267.
      View in: PubMed
    2. Deedwania P. Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs. J Am Coll Cardiol. 2018 Oct 09; 72(15):1787-1789. PMID: 30286921.
      View in: PubMed
    3. Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E. American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations. J Am Heart Assoc. 2018 Aug 07; 7(15):e009271. PMID: 30371251.
      View in: PubMed
    4. Lam PH, Gupta N, Dooley DJ, Singh S, Deedwania P, Zile MR, Bhatt DL, Morgan CJ, Pitt B, Fonarow GC, Ahmed A. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate. Am J Med. 2018 Dec; 131(12):1473-1481. PMID: 30076815.
      View in: PubMed
    5. Chatterjee S, Bandyopadhyay D, Ghosh RK, Majumdar U, Aneja A, Lavie CJ, Deedwania P. SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality? Curr Probl Cardiol. 2018 Jul 06. PMID: 30195639.
      View in: PubMed
    6. Lavie CJ, Deedwania P, Ortega FB. Obesity is rarely healthy. Lancet Diabetes Endocrinol. 2018 Sep; 6(9):678-679. PMID: 29859910.
      View in: PubMed
    7. Deedwania P, Lavie CJ. Dangers and Long-Term Outcomes in Metabolically Healthy Obesity: The Impact of the Missing Fitness Component. J Am Coll Cardiol. 2018 May 01; 71(17):1866-1868. PMID: 29699612.
      View in: PubMed
    8. Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, Deedwania P, Butler J, Aronow WS, Yancy CW, Fonarow GC, Ahmed A. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2018 Apr 01; 3(4):288-297. PMID: 29450487.
      View in: PubMed
    9. Gupta R, Gupta VP, Prakash H, Agrawal A, Sharma KK, Deedwania PC. 25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch. Indian Heart J. 2018 Nov - Dec; 70(6):802-807. PMID: 30580848.
      View in: PubMed
    10. Deedwania P, Weber M, Reimitz PE, Bakris G. Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status. J Clin Hypertens (Greenwich). 2017 Dec; 19(12):1309-1318. PMID: 29067756.
      View in: PubMed
    11. Deedwania P, Acharya T. Hearty Breakfast for Healthier Arteries. J Am Coll Cardiol. 2017 Oct 10; 70(15):1843-1845. PMID: 28982496.
      View in: PubMed
    12. Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2017 Oct 10; 70(15):1861-1871. PMID: 28982499.
      View in: PubMed
    13. Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. Eur J Heart Fail. 2018 02; 20(2):359-369. PMID: 28980368.
      View in: PubMed
    14. Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Lancet Diabetes Endocrinol. 2017 12; 5(12):941-950. PMID: 28927706.
      View in: PubMed
    15. Tsimploulis A, Sheriff HM, Anker MS, Deedwania P, Fletcher RD, Aronow WS, Anker SD, Ahmed A. Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?! Int J Cardiol. 2017 09 01; 242:21. PMID: 28619324.
      View in: PubMed
    16. Sheriff HM, Thogaripally MR, Panjrath G, Arundel C, Zeng Q, Fonarow GC, Butler J, Fletcher RD, Morgan C, Blackman MR, Deedwania P, Love TE, Aronow WS, Anker SD, Allman RM, Ahmed A. Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure. J Am Med Dir Assoc. 2017 Sep 01; 18(9):761-765. PMID: 28501416.
      View in: PubMed
    17. Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A. Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16]. Int J Cardiol. 2017 07 01; 238:181. PMID: 28487149.
      View in: PubMed
    18. Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM. Updated risk factors should be used to predict development of diabetes. J Diabetes Complications. 2017 May; 31(5):859-863. PMID: 28319004.
      View in: PubMed
    19. Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A. Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. Int J Cardiol. 2017 May 15; 235:11-16. PMID: 28291625.
      View in: PubMed
    20. Sheriff HM, Tsimploulis A, Valentova M, Anker MS, Deedwania P, Banach M, Morgan CJ, Blackman MR, Fonarow GC, White M, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A. Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study. Int J Cardiol. 2017 Jul 01; 238:140-143. PMID: 28343761.
      View in: PubMed
    21. Deedwania P, Acharya T, Kotak K, Fonarow GC, Cannon CP, Laskey WK, Peacock WF, Pan W, Bhatt DL. Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program. Am Heart J. 2017 May; 187:78-87. PMID: 28454811.
      View in: PubMed
    22. Deedwania P, Acharya T. Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting? J Am Coll Cardiol. 2017 Feb 21; 69(7):786-788. PMID: 28209219.
      View in: PubMed
    23. Lam PH, Dooley DJ, Inampudi C, Arundel C, Fonarow GC, Butler J, Wu WC, Blackman MR, Anker MS, Deedwania P, White M, Prabhu SD, Morgan CJ, Love TE, Aronow WS, Allman RM, Ahmed A. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone. Int J Cardiol. 2017 Jan 15; 227:462-466. PMID: 27866868.
      View in: PubMed
    24. Srikanth S, Deedwania P. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome. Curr Hypertens Rep. 2016 10; 18(10):76. PMID: 27730495.
      View in: PubMed
    25. Borer JS, Deedwania PC, Kim JB, Böhm M. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease. Am J Cardiol. 2016 Dec 15; 118(12):1948-1953. PMID: 27780557.
      View in: PubMed
    26. Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes. Int J Cardiol. 2016 Nov 01; 222:548-556. PMID: 27513651.
      View in: PubMed
    27. Arundel C, Lam PH, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure. Am J Med. 2016 Nov; 129(11):1178-1184. PMID: 27401949.
      View in: PubMed
    28. Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. Am J Med. 2016 10; 129(10):1067-73. PMID: 27262781.
      View in: PubMed
    29. Deedwania P, Acharya T. Mechanical Circulatory Support and Rationale for Future Research-Reply. JAMA Intern Med. 2016 05 01; 176(5):715-6. PMID: 27136339.
      View in: PubMed
    30. Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Apr 15; 117(8):1199-205. PMID: 26940556.
      View in: PubMed
    31. Deedwania P, Acharya T. Is Increased Use of Mechanical Circulatory Support Devices Justified? A Cause for Concern. JAMA Intern Med. 2015 Dec; 175(12):1982-3. PMID: 26523417.
      View in: PubMed
    32. Deedwania PC, Stone PH, Fayyad RS, Laskey RE, Wilson DJ. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65. PMID: 26625880; PMCID: PMC4676790.
    33. Kiel RG, Deedwania P. The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified? Expert Opin Drug Saf. 2015; 14(12):1855-63. PMID: 26488593.
      View in: PubMed
    34. Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation. Am J Cardiol. 2015 Dec 15; 116(12):1852-7. PMID: 26611122.
      View in: PubMed
    35. Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 2015 Sep 22; 66(12):1378-91. PMID: 26383726.
      View in: PubMed
    36. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-122.e1. PMID: 26699442.
      View in: PubMed
    37. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care. 2015 Sep; 38(9):1777-803. PMID: 26246459; PMCID: PMC4876675.
    38. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015 Aug 25; 132(8):691-718. PMID: 26246173.
      View in: PubMed
    39. Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail. 2015 Oct; 17(10):1050-6. PMID: 26011677.
      View in: PubMed
    40. Ahmed AA, Patel K, Nyaku MA, Kheirbek RE, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Fletcher RD, Aronow WS, Ahmed A. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. Circ Heart Fail. 2015 Jul; 8(4):694-701. PMID: 26038535.
      View in: PubMed
    41. Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC. Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study. J Glob Health. 2015 Jun; 5(1):010411. PMID: 25969733; PMCID: PMC4416330.
    42. Aftab W, Gazallo J, Motabar A, Varadrajan P, Deedwania PC, Pai RG. Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation. Int J Angiol. 2015 Jun; 24(2):105-12. PMID: 26060381; PMCID: PMC4452604.
    43. Acharya T, Deedwania P. An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation. Core Evid. 2015; 10:63-73. PMID: 26019695.
      View in: PubMed
    44. Gupta B, Gupta R, Sharma KK, Gupta A, Mahanta TG, Deedwania PC. Low Prevalence of AHA-Defined Ideal Cardiovascular Health Factors: A Study of Urban Indian Men and Women. Glob Heart. 2017 09; 12(3):219-225. PMID: 26014652.
      View in: PubMed
    45. Deedwania P. Gaps in guideline implementation: a cause for concern, time for action. J Am Coll Cardiol. 2015 Jan 27; 65(3):278-80. PMID: 25614425.
      View in: PubMed
    46. Gupta R, Sharma KK, Gupta BK, Gupta A, Gupta RR, Deedwania PC. Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in India. Heart Asia. 2015; 7(1):1-6. PMID: 27326202.
      View in: PubMed
    47. Deedwania PC. Management of Patients With Stable Angina and Type 2 Diabetes. Rev Cardiovasc Med. 2015; 16(2):105-13. PMID: 26198557.
      View in: PubMed
    48. Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. Am J Med. 2015 Jul; 128(7):715-21. PMID: 25554369.
      View in: PubMed
    49. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. PLoS One. 2014; 9(12):e114519. PMID: 25531109; PMCID: PMC4273994.
    50. Jones LG, Sin MK, Hage FG, Kheirbek RE, Morgan CJ, Zile MR, Wu WC, Deedwania P, Fonarow GC, Aronow WS, Prabhu SD, Fletcher RD, Ahmed A, Allman RM. Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST). Circ Heart Fail. 2015 Jan; 8(1):17-24. PMID: 25480782; PMCID: PMC4377074.
    51. Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Deedwania PC. Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India. BMJ Open Diabetes Res Care. 2014; 2(1):e000048. PMID: 25489485; PMCID: PMC4256307.
    52. Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. Am J Med. 2015 Apr; 128(4):426.e1-9. PMID: 25433302.
      View in: PubMed
    53. Inampudi C, Deedwania P, Fonarow GC, Sanders PW, Aronow WS, Ahmed A. Reply: To PMID 24846806. Am J Cardiol. 2015 Jan 01; 115(1):156. PMID: 25454018.
      View in: PubMed
    54. Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015 Mar; 128(3):219-28. PMID: 25447617.
      View in: PubMed
    55. Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, Deedwania P, Aronow WS, Anker SD, Ahmed A. Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):945-52. PMID: 25296862; PMCID: PMC4997614.
    56. White M, Patel K, Caldentey G, Deedwania P, Kheirbek R, Fletcher RD, Aban IB, Lo A, Aronow WS, Fonarow GC, Anker SD, Ahmed A. Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction. Int J Cardiol. 2014 Nov 15; 177(1):255-60. PMID: 25499389.
      View in: PubMed
    57. Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. Am J Cardiol. 2014 Sep 15; 114(6):909-13. PMID: 25208562.
      View in: PubMed
    58. Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, Gupta A. High prevalence of metabolic syndrome among urban subjects in India: a multisite study. Diabetes Metab Syndr. 2014 Jul-Sep; 8(3):156-61. PMID: 25220918.
      View in: PubMed
    59. Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). Am J Cardiol. 2014 Jul 01; 114(1):79-82. PMID: 24846806; PMCID: PMC4169696.
    60. Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK. Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J. 2014 May-Jun; 66(3):280-8. PMID: 24973832; PMCID: PMC4121768.
    61. Deedwania PC. Statins in chronic kidney disease: cardiovascular risk and kidney function. Postgrad Med. 2014 Jan; 126(1):29-36. PMID: 24393749.
      View in: PubMed
    62. Kiel RG, Deedwania P. Medical treatment of hypertension in patients with heart failure with preserved ejection fraction. Curr Cardiol Rep. 2013 Dec; 15(12):428. PMID: 24162922.
      View in: PubMed
    63. Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med. 2014 Jan; 127(1):61-70. PMID: 24257326; PMCID: PMC3929967.
    64. Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014 Jan; 127(1):71-81.e1. PMID: 24210549.
      View in: PubMed
    65. Deedwania P. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs. 2013 Sep; 73(14):1569-86. PMID: 24065301; PMCID: PMC3786091.
    66. Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial. Eur Heart J. 2014 Jul 14; 35(27):1801-8. PMID: 23990605.
      View in: PubMed
    67. Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A. Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. Int J Cardiol. 2013 Oct 09; 168(4):3616-22. PMID: 23731526; PMCID: PMC3939803.
    68. Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM. A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol. 2013 Jul 15; 112(2):231-7. PMID: 23608615.
      View in: PubMed
    69. Deedwania P. Diabetes, cardiovascular disease, and ethnicity. J Am Coll Cardiol. 2013 Apr 30; 61(17):1787-9. PMID: 23500320.
      View in: PubMed
    70. Lardizabal JA, Deedwania PC. Primary Prevention of Atrial Fibrillation - The Path Untread. J Atr Fibrillation. 2013 Feb-Mar; 5(5):567. PMID: 28496805.
      View in: PubMed
    71. Deedwania P, Shea J, Chen W, Brener L. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. J Clin Hypertens (Greenwich). 2013 Apr; 15(4):270-8. PMID: 23551727.
      View in: PubMed
    72. Deedwania PC. New oral anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2013 Apr; 126(4):289-96. PMID: 23369212.
      View in: PubMed
    73. Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013 Jan; 26(1):83-94. PMID: 23382331.
      View in: PubMed
    74. Deedwania PC. Ivabradine in heart failure: hope or hype? Am J Cardiovasc Drugs. 2012 Dec 01; 12(6):357-9. PMID: 23181943.
      View in: PubMed
    75. Deedwania P, Ahmed A. Prediabetes and the risk of diabetes. Lancet. 2012 Oct 06; 380(9849):1225; author reply 1226. PMID: 23040849.
      View in: PubMed
    76. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL. ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 03; 308(13):1340-9. PMID: 23032550.
      View in: PubMed
    77. Rathi S, Deedwania PC. The epidemiology and pathophysiology of heart failure. Med Clin North Am. 2012 Sep; 96(5):881-90. PMID: 22980052.
      View in: PubMed
    78. Deedwania PC. Heart failure: a common and complex clinical syndrome. Med Clin North Am. 2012 Sep; 96(5):xi-xii. PMID: 22980062.
      View in: PubMed
    79. Deedwania PC, Carbajal E. Evidence-based therapy for heart failure. Med Clin North Am. 2012 Sep; 96(5):915-31. PMID: 22980055.
      View in: PubMed
    80. Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R. Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study. PLoS One. 2012; 7(8):e44098. PMID: 22952886; PMCID: PMC3430674.
    81. Lardizabal JA, Deedwania PC. Atrial fibrillation in heart failure. Med Clin North Am. 2012 Sep; 96(5):987-1000. PMID: 22980060.
      View in: PubMed
    82. Deedwania P, Huang GW. An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. Core Evid. 2012; 7:49-59. PMID: 22826692; PMCID: PMC3402013.
    83. Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21. PMID: 22747613.
      View in: PubMed
    84. Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012 Apr 26; 4(4):112-20. PMID: 22558490.
      View in: PubMed
    85. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012 Apr 24; 125(16):1979-87. PMID: 22461416; PMCID: PMC3338158.
    86. Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15; 109(12):1761-6. PMID: 22459310; PMCID: PMC4454417.
    87. Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan; 5(1):126-33. PMID: 22235068.
      View in: PubMed
    88. Deedwania P, Huang GW. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. Rev Cardiovasc Med. 2012; 13(2-3):e89-104. PMID: 23160166.
      View in: PubMed
    89. Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. Circ Cardiovasc Genet. 2012 Feb 01; 5(1):51-7. PMID: 22135385.
      View in: PubMed
    90. Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C. Polymorphisms and noncardioembolic stroke in three case-control studies. Cerebrovasc Dis. 2012; 33(1):80-5. PMID: 22134093.
      View in: PubMed
    91. Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC. Twenty-year trends in cardiovascular risk factors in India and influence of educational status. Eur J Prev Cardiol. 2012 Dec; 19(6):1258-71. PMID: 21947630.
      View in: PubMed
    92. Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A. A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults. Am J Cardiol. 2011 Dec 15; 108(12):1747-53. PMID: 21943936; PMCID: PMC3324944.
    93. Deedwania P. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes. Ann Intern Med. 2011 Aug 16; 155(4):JC2-12. PMID: 21844545.
      View in: PubMed
    94. Deedwania PC, Huang GW. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. Am J Cardiovasc Drugs. 2011 Aug 01; 11(4):265-75. PMID: 21740079.
      View in: PubMed
    95. Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol. 2011 Aug 01; 108(3):360-6. PMID: 21757044.
      View in: PubMed
    96. Deedwania PC, Carbajal EV. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. Am J Med. 2011 Aug; 124(8):681-8. PMID: 21787900.
      View in: PubMed
    97. Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A. Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving ß-blockers: insights from the BEST trial. Int J Cardiol. 2013 Feb 10; 163(1):61-7. PMID: 21704392; PMCID: PMC3395778.
    98. Deedwania PC. Blood pressure control in diabetes mellitus: is lower always better, and how low should it go? Circulation. 2011 Jun 21; 123(24):2776-8. PMID: 21690500.
      View in: PubMed
    99. Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A. Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. Int J Cardiol. 2012 Feb 23; 155(1):120-5. PMID: 21664707; PMCID: PMC3640328.
    100. Bharani A, Jain N, Jain A, Deedwania P. Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents. Indian Heart J. 2011 May-Jun; 63(3):255-8. PMID: 22734346.
      View in: PubMed
    101. Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur J Heart Fail. 2011 May; 13(5):551-9. PMID: 21393298; PMCID: PMC3079464.
    102. Fonseca V, Sharma PP, Shah M, Deedwania P. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011 Apr; 27(4):799-807. PMID: 21306286.
      View in: PubMed
    103. Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011 Apr 15; 107(8):1208-14. PMID: 21296319; PMCID: PMC3072746.
    104. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb; 161(2):418-424.e1-3. PMID: 21404720.
      View in: PubMed
    105. Lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr Atheroscler Rep. 2011 Feb; 13(1):43-50. PMID: 21107759; PMCID: PMC3018271.
    106. Gupta R, Deedwania P. Interventions for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):15-34. PMID: 21257098.
      View in: PubMed
    107. Deedwania P. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention. Cardiol Clin. 2011 Feb; 29(1):xi-xiii. PMID: 21257096.
      View in: PubMed
    108. Srikanth S, Deedwania P. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin. 2011 Feb; 29(1):47-70. PMID: 21257100.
      View in: PubMed
    109. Vijayaraghavan K, Deedwania P. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):137-56. PMID: 21257105.
      View in: PubMed
    110. Carbajal EV, Deedwania P. Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease. Cardiol Clin. 2011 Feb; 29(1):157-65. PMID: 21257106.
      View in: PubMed
    111. Lardizabal JA, Deedwania P. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol Clin. 2011 Feb; 29(1):87-103. PMID: 21257102.
      View in: PubMed
    112. Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A. Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study. Ann Med. 2012 May; 44(3):253-61. PMID: 21254894; PMCID: PMC3116996.
    113. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol. 2011 Jan 04; 57(1):63-9. PMID: 21185503.
      View in: PubMed
    114. Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A. Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. Am J Cardiol. 2011 Feb 15; 107(4):552-7. PMID: 21185004; PMCID: PMC3053576.
    115. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010 Dec; 160(6):1130-6, 1136.e1-3. PMID: 21146668.
      View in: PubMed
    116. Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating ß-blockers. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):52-9. PMID: 21214722.
      View in: PubMed
    117. Lardizabal JA, Deedwania PC. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep. 2010 Nov; 12(6):464-71. PMID: 20809236; PMCID: PMC2939350.
    118. Singh V, Sharma R, Kumar A, Deedwania P. Low high-density lipoprotein cholesterol: current status and future strategies for management. Vasc Health Risk Manag. 2010 Oct 29; 6:979-96. PMID: 21127701; PMCID: PMC2988622.
    119. Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A. Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol. 2012 Jan 26; 154(2):128-33. PMID: 20947188; PMCID: PMC3116091.
    120. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail. 2011 Feb; 13(2):200-6. PMID: 20930001; PMCID: PMC3025667.
    121. Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag. 2010 Oct 05; 6:843-53. PMID: 20957130; PMCID: PMC2952453.
    122. Deedwania PC. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus". Arch Intern Med. 2010 Sep 27; 170(17):1575-7. PMID: 20876409.
      View in: PubMed
    123. Srikanth S, Deedwania P. Hypertension as a cardiometabolic risk. Indian Heart J. 2010 Sep-Oct; 62(5):394-401. PMID: 23189879.
      View in: PubMed
    124. Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9. PMID: 20498618; PMCID: PMC2908201.
    125. Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol. 2010 Jul 15; 106(2):221-7. PMID: 20599007; PMCID: PMC2945308.
    126. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Apr 01; 105(7):905-11. PMID: 20346304.
      View in: PubMed
    127. Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1463-76. PMID: 20228402.
      View in: PubMed
    128. McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1477-90. PMID: 20228403.
      View in: PubMed
    129. Lardizabal JA, Deedwania PC. The current state of beta blockers in hypertension therapy. Indian Heart J. 2010 Mar-Apr; 62(2):111-7. PMID: 21180299.
      View in: PubMed
    130. Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010 Mar; 123(3):198-204. PMID: 20193823.
      View in: PubMed
    131. Stein PK, Deedwania P. New York Heart Association functional class influences the impact of diabetes on cardiac autonomic function. J Electrocardiol. 2010 Sep-Oct; 43(5):379-84. PMID: 20096854.
      View in: PubMed
    132. LaRosa JC, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A. Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Feb 01; 105(3):283-7. PMID: 20102935.
      View in: PubMed
    133. Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vasc Health Risk Manag. 2009; 5:1007-14. PMID: 19997570; PMCID: PMC2788593.
    134. Deedwania P, Singh V, Davidson MH. Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials. Am J Cardiol. 2009 Nov 16; 104(10 Suppl):3E-9E. PMID: 19895938.
      View in: PubMed
    135. Kosiborod M, Deedwania P. An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol. 2009 Nov 01; 3(6):1342-51. PMID: 20144388; PMCID: PMC2787034.
    136. Javed U, Deedwania PC. Beta-adrenergic blockers for chronic heart failure. Cardiol Rev. 2009 Nov-Dec; 17(6):287-92. PMID: 19829179.
      View in: PubMed
    137. Singh V, Deedwania P. Reducing morbidity and mortality in high risk patients with statins. Vasc Health Risk Manag. 2009; 5(2):495-507. PMID: 19554090; PMCID: PMC2697584.
    138. Stein PK, Deedwania P. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study). Am J Cardiol. 2009 Jun 01; 103(11):1495-9. PMID: 19463505.
      View in: PubMed
    139. Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. J Am Soc Hypertens. 2009 May-Jun; 3(3):210-20. PMID: 20409961.
      View in: PubMed
    140. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009 Jan 20; 53(3):298-304. PMID: 19147051.
      View in: PubMed
    141. Deedwania P. Contemporary approaches for cardiovascular risk reduction in diabetes. Indian Heart J. 2009 Jan-Feb; 61(1):24-33. PMID: 19729685.
      View in: PubMed
    142. Deedwania PC, Carbajal EV. Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state. Rev Cardiovasc Med. 2009; 10 Suppl 1:S11-20. PMID: 19898283.
      View in: PubMed
    143. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009 Jan 20; 119(2):351-7. PMID: 19095622.
      View in: PubMed
    144. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009 Jan; 32(1):187-92. PMID: 19092168; PMCID: PMC2606812.
    145. Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2008 Dec; 10(12):894-903. PMID: 19120715.
      View in: PubMed
    146. Javed U, Deedwania PC. Angiotensin receptor blockers: novel role in high-risk patients. Cardiol Clin. 2008 Nov; 26(4):507-26. PMID: 18929228.
      View in: PubMed
    147. Deedwania PC, Javed U. Statins in heart failure. Cardiol Clin. 2008 Nov; 26(4):573-87. PMID: 18929232.
      View in: PubMed
    148. Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009 Jan; 157(1):111-117.e2. PMID: 19081406.
      View in: PubMed
    149. Deedwania P. The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism. Int J Cardiol. 2009 Jan 24; 131(3):305-12. PMID: 18715660.
      View in: PubMed
    150. Ram CV, Deedwania PC. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Am J Cardiol. 2008 Nov 01; 102(9):1281-3. PMID: 18940307.
      View in: PubMed
    151. Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc. 2008 Aug; 83(8):870-9. PMID: 18674471.
      View in: PubMed
    152. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology. 2008 Jul; 109(1):14-24. PMID: 18580168.
      View in: PubMed
    153. Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol. 2008 Oct; 19(10):1037-42. PMID: 18554193.
      View in: PubMed
    154. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008 Jun 10; 117(23):3002-9. PMID: 18519851.
      View in: PubMed
    155. Singh V, Deedwania P. Expanding roles for atorvastatin. Drugs Today (Barc). 2008 Jun; 44(6):455-71. PMID: 18596999.
      View in: PubMed
    156. Kostis JB, Breazna A, Deedwania PC, LaRosa JC. The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study. J Clin Hypertens (Greenwich). 2008 May; 10(5):367-76. PMID: 18453796.
      View in: PubMed
    157. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008 Apr 15; 51(15):1448-54. PMID: 18402899.
      View in: PubMed
    158. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008 Mar 25; 117(12):1610-9. PMID: 18299505.
      View in: PubMed
    159. Gupta R, Gupta VP, Bhagat N, Rastogi P, Sarna M, Prakash H, Deedwania PC. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies. Indian Heart J. 2008 Jan-Feb; 60(1):26-33. PMID: 19212018.
      View in: PubMed
    160. Deedwania P, Srikanth S. Diabetes and vascular disease. Expert Rev Cardiovasc Ther. 2008 Jan; 6(1):127-38. PMID: 18095912.
      View in: PubMed
    161. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007 Dec 04; 50(23):2264-74. PMID: 18061078.
      View in: PubMed
    162. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007 Dec 04; 116(23):2762-72. PMID: 17998462.
      View in: PubMed
    163. Deedwania P. Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients. J Clin Hypertens (Greenwich). 2007 Nov; 9(11):883-8. PMID: 17978596.
      View in: PubMed
    164. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1131-9. PMID: 17942759.
      View in: PubMed
    165. Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials. Stroke. 2007 Nov; 38(11):2965-71. PMID: 17885258.
      View in: PubMed
    166. Srikanth S, Deedwania P. Management of coronary artery disease in patients with type 2 diabetes mellitus. Curr Cardiol Rep. 2007 Jul; 9(4):264-71. PMID: 17601392.
      View in: PubMed
    167. Deedwania PC, Gupta M, Stein M, Ycas J, Gold A. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial). Am J Cardiol. 2007 Jun 01; 99(11):1538-43. PMID: 17531577.
      View in: PubMed
    168. Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007 Apr 17; 115(15):1975-81. PMID: 17420346.
      View in: PubMed
    169. Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation. 2007 Feb 13; 115(6):700-7. PMID: 17283260.
      View in: PubMed
    170. Deedwania PC, Smith DG. Clinical efficacy and cost-effectiveness of rosuvastatin. Expert Rev Pharmacoecon Outcomes Res. 2007 Feb; 7(1):31-9. PMID: 20528428.
      View in: PubMed
    171. Deedwania PC, Carbajal EV, Bobba VR. Trials and tribulations associated with angina and traditional therapeutic approaches. Clin Cardiol. 2007 Feb; 30(2 Suppl 1):I16-24. PMID: 18373326.
      View in: PubMed
    172. Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007 Feb 06; 115(5):576-83. PMID: 17261662.
      View in: PubMed
    173. Stein PK, Tereshchenko L, Domitrovich PP, Kleiger RE, Perez A, Deedwania P. Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure. Eur J Heart Fail. 2007 Apr; 9(4):364-9. PMID: 17123863.
      View in: PubMed
    174. Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet. 2006 Sep 09; 368(9539):919-28. PMID: 16962881.
      View in: PubMed
    175. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006 Jun; 29(6):1220-6. PMID: 16731999.
      View in: PubMed
    176. Deedwania PC, Schmieder R. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2006 Jun; 7 Suppl 1:S12-8. PMID: 16986230.
      View in: PubMed
    177. Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade. Am J Cardiol. 2006 May 22; 97(10A):26F-33F. PMID: 16698332.
      View in: PubMed
    178. Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). J Cardiometab Syndr. 2006; 1(5):295-300. PMID: 17679790.
      View in: PubMed
    179. Singh V, Deedwania P. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics. Curr Atheroscler Rep. 2006 Jan; 8(1):32-40. PMID: 16455012.
      View in: PubMed
    180. Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. J Card Fail. 2005 Dec; 11(9):647-56. PMID: 16360958.
      View in: PubMed
    181. Deedwania P, Singh V. Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J. 2005 Nov-Dec; 57(6):617-31. PMID: 16521627.
      View in: PubMed
    182. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med. 2005 Sep; 118(9):939-47. PMID: 16164876.
      View in: PubMed
    183. Deedwania P. Avoid the rush to judgment in acute coronary syndromes. Postgrad Med. 2005 Sep; 118(3):11-4, 22. PMID: 16201303.
      View in: PubMed
    184. Carbajal EV, Deedwania P. Treating non-ST-segment elevation ACS. Pros and cons of current strategies. Postgrad Med. 2005 Sep; 118(3):23-32. PMID: 16201305.
      View in: PubMed
    185. Amsterdam EA, Deedwania P. Bedside evaluation of cardiac markers. Point-of-care testing can differentiate acute coronary syndromes. Postgrad Med. 2005 Sep; 118(3):15-6, 19-22. PMID: 16201304.
      View in: PubMed
    186. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63. PMID: 16098311.
      View in: PubMed
    187. Deedwania P. Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary. Evid Based Cardiovasc Med. 2005 Sep; 9(3):241-4. PMID: 16380043.
      View in: PubMed
    188. Deedwania PC, Volkova N. Current Treatment Options for the Metabolic Syndrome. Curr Treat Options Cardiovasc Med. 2005 May; 7(1):61-74. PMID: 15913505.
      View in: PubMed
    189. Vijayaraghavan K, Deedwania PC. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications. Cardiol Clin. 2005 May; 23(2):165-83. PMID: 15694745.
      View in: PubMed
    190. Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Cardiol Clin. 2005 May; 23(2):139-52. PMID: 15694743.
      View in: PubMed
    191. Deedwania P, Volkova N. Dyslipidemia and lipid-lowering therapy in the elderly. Expert Rev Cardiovasc Ther. 2005 May; 3(3):453-63. PMID: 15889973.
      View in: PubMed
    192. Srikanth S, Deedwania P. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach. Cardiol Clin. 2005 May; 23(2):193-210. PMID: 15694747.
      View in: PubMed
    193. Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol. 2005 Feb 01; 95(3):360-6. PMID: 15670545.
      View in: PubMed
    194. Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol. 2005 Jan 18; 45(2):252-9. PMID: 15653024.
      View in: PubMed
    195. Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J. 2005 Jan; 149(1):159-67. PMID: 15660048.
      View in: PubMed
    196. Deedwania PC. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Am Heart J. 2004 Dec; 148(6):1053-9. PMID: 15632893.
      View in: PubMed
    197. Ghali JK, Dunselman P, Waagstein F, Goldstein S, Gottlieb SS, Deedwania PC, Wikstrand JC. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis. J Card Fail. 2004 Dec; 10(6):452-9. PMID: 15599834.
      View in: PubMed
    198. Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004 Nov; 22(4):485-504. PMID: 15501618.
      View in: PubMed
    199. Deedwania PC. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Cardiol Clin. 2004 Nov; 22(4):505-9, v. PMID: 15501619.
      View in: PubMed
    200. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004 Nov; 97(2):257-61. PMID: 15458693.
      View in: PubMed
    201. Deedwania PC, Davidson MH, Ballantyne CM. Treating dyslipidemia in high-risk patients: case reviews and discussion. Postgrad Med. 2004 Sep; 116(3 Suppl):21-8. PMID: 19667672.
      View in: PubMed
    202. Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J. 2004 Aug; 25(15):1300-9. PMID: 15288157.
      View in: PubMed
    203. Deedwania PC, Hunninghake DB, Bays H. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. Am J Cardiol. 2004 Jun 03; 93(11A):18C-26C. PMID: 15178513.
      View in: PubMed
    204. Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation. 2004 Jan 06; 109(1):2-4. PMID: 14707015.
      View in: PubMed
    205. Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63. PMID: 14583895.
      View in: PubMed
    206. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 03; 42(5):914-22. PMID: 12957443.
      View in: PubMed
    207. Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Card Electrophysiol Rev. 2003 Sep; 7(3):264-75. PMID: 14739726.
      View in: PubMed
    208. Goldstein S, Deedwania P, Gottlieb S, Wikstrand J. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure). Am J Cardiol. 2003 Aug 15; 92(4):478-80. PMID: 12914886.
      View in: PubMed
    209. Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep. 2003 Aug; 3(4):289-92. PMID: 12866990.
      View in: PubMed
    210. Ravnan SL, Deedwania PC. The rational use of diuretics in heart failure. Curr Cardiol Rep. 2003 May; 5(3):237-42. PMID: 12691643.
      View in: PubMed
    211. Deedwania PC. The key to unraveling the mystery of mortality in heart failure: an integrated approach. Circulation. 2003 Apr 08; 107(13):1719-21. PMID: 12682028.
      View in: PubMed
    212. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 07; 107(1):149-58. PMID: 12515758.
      View in: PubMed
    213. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003 Jan 01; 41(1):159-68. PMID: 12570960.
      View in: PubMed
    214. Deedwania PC. Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease. Am J Cardiol. 2003 Jan 01; 91(1):68-71. PMID: 12505574.
      View in: PubMed
    215. Deedwania PC. Heart failure in the elderly: is beta-blockade the standard of care? Postgrad Med. 2002 Dec; 112(6 Suppl Heart):21-7. PMID: 19667614.
      View in: PubMed
    216. Matalka MS, Ravnan MC, Deedwania PC. Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). Am Heart J. 2002 Oct; 144(4):674-7. PMID: 12360164.
      View in: PubMed
    217. Reynolds HQ, Deedwania PC. Treating hypertension in patients with diabetes. Nurse Pract. 2002 Jul; 27(7):11-21; quiz 21-3. PMID: 12131797.
      View in: PubMed
    218. Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol. 2002 May 01; 39(9):1456-63. PMID: 11985907.
      View in: PubMed
    219. Ghali JK, Piña IL, Gottlieb SS, Deedwania PC, Wikstrand JC. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation. 2002 Apr 02; 105(13):1585-91. PMID: 11927527.
      View in: PubMed
    220. Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study). Am Heart J. 2002 Apr; 143(4):636-42. PMID: 11923800.
      View in: PubMed
    221. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation. 2002 Mar 12; 105(10):1182-8. PMID: 11889011.
      View in: PubMed
    222. Deedwania PC. The changing face of hypertension: is systolic blood pressure the final answer? Arch Intern Med. 2002 Mar 11; 162(5):506-8. PMID: 11871917.
      View in: PubMed
    223. Ravnan SL, Ravnan MC, Deedwania PC. Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure. Congest Heart Fail. 2002 Mar-Apr; 8(2):80-5. PMID: 11927781.
      View in: PubMed
    224. Deedwania PC. Clinical significance of cardiovascular dysmetabolic syndrome. Curr Control Trials Cardiovasc Med. 2002 Jan 07; 3(1):2. PMID: 11985776.
      View in: PubMed
    225. Gorwit J, Haidet GC, Russell DC, Tonkon M, Deedwania PC, Borer JS. Randomized Placebo-Controlled Withdrawal Study of Amlodipine in Agina Pectoris. Am J Ther. 1995 Jan; 2(1):34-42. PMID: 11850645.
      View in: PubMed